Mj. Coffey et al., Peroxynitrite-induced nitrotyrosination of proteins is blocked by direct 5-lipoxygenase inhibitor zileuton, J PHARM EXP, 299(1), 2001, pp. 198-203
Citations number
41
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
We have previously shown that the ability of overnight pretreatment with li
popolysaccharide (LPS) to suppress alveolar macrophage (AM) leukotrienes (L
T) synthesis is explained by induction of nitric oxide (NO), and reactive o
xygen intermediates (ROI). More recently we have demonstrated that the gene
ration of peroxynitrite (ONOO-) from the combination of NO and ROI directly
nitrotyrosinates the 5-lipoxygenase (5-LO) enzyme and reduces cell-free an
d intact AM 5-LO metabolism. This effect of ONOO- was associated with nitro
tyrosination of the 5-LO enzyme in intact cells and after treatment of reco
mbinant enzyme. We postulated that LPS treatment of cells resulted in activ
ation of 5-LO with the generation of ROI, which in turn led to autoinactiva
tion of the enzyme. In an effort to suppress ROI generated from activation
of 5-LO we examined the effect of a direct 5-LO inhibitor on LPS-induced su
ppression of LT synthesis. Coincubation with the reversible 5-LO inhibitor
zileuton during the LPS pretreatment of intact cells dose dependently block
ed the inhibition of 5-LO metabolism by LPS. The effect of zileuton on LPS-
induced suppression of LT synthesis was similar to that of N-monomethyl-L-a
rginine. Zileuton had no effect on inducible nitric-oxide synthase inductio
n. Interestingly, zileuton blocked ONOO--induced nitrotyrosination of recom
binant 5-LO in a cell-free system as well as of native enzyme in intact cel
ls. Moreover, zileuton blocked the nitrotyrosination of other proteins. We
conclude that the suppression of 5-LO activity occurring with LPS treatment
can be blocked by zileuton. The mechanism by which zileuton is effective i
s in part explained by blocking nitrotyrosination of 5-LO.